FrancophonIA/ELRC3.0 huggingface dataset:
English: Acute bacterial exacerbations of chronic bronchitis (adequately diagnosed according to national and/or local guidelines on the treatment of respiratory tract infections) in patients with severe underlying COPD and/or other risk factors, or in case of known or suspected bacterial resistance to commonly used classes of anti-infectives (according to history of patients or national and /or regional resistance data), or if previous anti-infective treatment has failed.
Slovenian: Akutne bakterijske eksacerbacije kroničnega bronhitisa (ustrezno diagnosticirane v skladu z nacionalnimi in/ali lokalnimi smernicami za zdravljenje okužb dihal) pri bolnikih s hudo izhodiščno KOPB in/ali drugimi dejavniki tveganja, v primeru znane ali domnevne odpornosti bakterij na običajno uporabljene razrede protivnetnih zdravil (v skladu z anamnezo bolnikov ali nacionalnimi in/ali regijskimi podatki o odpornosti) ali če je bilo predhodno protivnetno zdravljenje neuspešno.
English: Therefore, levofloxacin is active against a diverse range of common causative pathogens for sinusitis, acute exacerbation of chronic bronchitis (AECB), community-acquired pneumonia (CAP), urinary tract infections (UTIs) and skin and soft tissue infections (SSTIs).
Slovenian: Levofloksacin tako deluje proti številnim pogostim patogenom, ki povzročajo sinusitis, akutno eksacerbacijo (nenadno poslabšanje) kroničnega bronhitisa (AEKB), zunajbolnišnično pljučnico (ZBP), okužbe sečil ter okužbe kože in mehkih tkiv (OKMT).
English: Levofloxacin is currently indicated in adults for the treatment of respiratory tract infections (RTIs), SSTIs, complicated and uncomplicated UTIs and chronic bacterial prostatitis (CBP).
Slovenian: Levofloksacin je trenutno indiciran za uporabo pri odraslih za zdravljenje okužb dihal, okužb kože in mehkih tkiv, zapletenih in nezapletenih okužb sečil ter kroničnega bakterijskega prostatitisa.
English: A 750 mg strength in film coated tablet and as solution for infusion 750 mg/150 ml was approved in some MS.
Slovenian: V nekaterih državah članicah je bila odobrena jakost 750 mg za filmsko obložene tablete in 750 mg/150 ml za raztopino za infundiranje.
English: the CHMP has recommended the variation to the terms of the marketing authorisations for which the summary of product characteristics, labelling and package leaflets are set out in Annex III for Tavanic and associated names (see Annex I).
Slovenian: • Odbor je soglašal z uskladitvijo povzetka glavnih značilnosti zdravila, označevanja in navodila za uporabo, ki so jo predlagali imetniki dovoljenja za promet z zdravili, je odbor CHMP priporočil spremembo pogojev dovoljenj za promet z zdravilom Tavanic in povezanimi imeni (glejte Prilogo I), katerih povzetek glavnih značilnosti zdravila, označevanje in navodilo za uporabo so določeni v Prilogi III .
English: Inhalation Anthrax
Slovenian: Inhalacijski vranični prisad
English: Due to the combination of the MRP and National granted MAs some divergent information has been identified in the product information (PI) for Tavanic.
Slovenian: Zaradi kombinacije postopka z medsebojnim priznavanjem in nacionalno odobrenih dovoljenj za promet z zdravilom je bilo v informacijah o zdravilu Tavanic ugotovljenih nekaj razhajanj.
English: Tavanic, film-coated tablets, 250 mg and 500mg
Slovenian: Usklajene terapevtske indikacije za zdravilo Tavanic, filmsko obložene tablete 250 mg in 500 mg ter za i.v.
English: Tablets - Inhalation Anthrax: post-exposure prophylaxis and curative treatment IV solution - Inhalation Anthrax: curative treatment
Slovenian: tablete - inhalacijski vranični prisad: profilaksa po izpostavitvi in kurativno zdravljenje; i.v.
English: • AECB (tablets only): 250 - 500 mg once daily for 7 - 10 days;
Slovenian: • AEKB (samo tablete): 250-500 mg enkrat dnevno za 7-10 dni;
English: Package Leaflet (PL)
Slovenian: Priloga II
English: For the above-mentioned infections Tavanic should be used only when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of these infections.
Slovenian: Za zgoraj navedene okužbe se zdravilo Tavanic uporablja le, kadar se uporaba splošno priporočenih protibakterijskih sredstev za začetno zdravljenje teh okužb šteje za neustrezno.
English: • Community-acquired pneumonia
Slovenian: • zunajbolnišnična pljučnica
English: Based on the review of all the data currently available, the MAH proposed to harmonise the wording for levofloxacin tablets and IV solution to be recommended in PN and complicated urinary tract infections with consideration being given to official guidance on the appropriate use of antibacterial agents.
Slovenian: raztopino levofloksacina, tako da bo priporočeno zdravljenje pielonefritisa in zapletenih okužb sečil z upoštevanjem uradnih smernic za ustrezno uporabo protibakterijskih sredstev.
English: Tavanic film coated tablets is indicated for the treatment of AECB in adults only when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of these infections.
Slovenian: Filmsko obložene tablete Tavanic so indicirane za zdravljenje AEKB pri odraslih osebah samo, kadar se uporaba splošno priporočenih protibakterijskih sredstev za začetno zdravljenje teh okužb šteje za neustrezno.
English: This indication has been approved for levofloxacin tablets in all MS identified above via nationally or MRP.
Slovenian: Ta indikacija je bila odobrena za tablete levofloksacina v vseh naštetih državah članicah z nacionalnim postopkom ali postopkom z medsebojnim priznavanjem.
English: The most important pathogens in these indications are S. pneumoniae, H. influenzae with the addition of intracellular/atypical bacteria for CAP. Hospital-acquired pneumonia (HAP) is also a RTI for which levofloxacin was approved for in two MS and for which the MAH is not pursuing its maintenance as summarised below.
Slovenian: Najpomembnejši patogeni pri teh indikacijah so S. pneumoniae, H. influenzae z dodanimi znotrajceličnimi/atipičnimi bakterijami za ZBP.
English: This indication has been approved in all MS for both tablets and IV formulation, except in one MS.
Slovenian: Ta indikacija ni bila odobrena v vseh državah članicah za obe vrsti tablet in za i.v.
English: • cSSTIs (tablets): 250mg once daily or 500 mg once or twice daily for 7 to 14 days;
Slovenian: • zapletene okužbe kože in mehkih tkiv (tablete): 250 mg enkrat dnevno ali 500 mg enkrat ali dvakrat dnevno za 7 do 14 dni;
English: Levofloxacin is also indicated in a few atypical indications like urosepsis, digestive and hepatobiliary infections, Anthrax curative treatment, and hospital-acquired pneumonia (HAP).
Slovenian: Uporablja se tudi za nekatere atipične indikacije, kot so urosepsa, okužbe prebavil, jeter, žolčnika in žolčevodov, za zdravljenje vraničnega prisada in bolnišnične pljučnice.
English: The MAH agreed that Tavanic film coated tablets is indicated for the treatment of ABS in adults only when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of these infections.
Slovenian: Imetnik dovoljenja za promet z zdravilom je soglašal, da so filmsko obložene tablete Tavanic indicirane za zdravljenje ABS pri odraslih samo, kadar se uporaba splošno priporočenih protibakterijskih sredstev za začetno zdravljenje teh okužb šteje za neustrezno.
English: The CAP indication is approved for both tablets and IV formulation of levofloxacin.
Slovenian: Indikacija ZBP je odobrena za tablete in i.v.
English: Respiratory Tract Infections (RTIs)
Slovenian: Zunajbolnišnična pljučnica (ZBP)
English: This indication is approved for both tablets and IV formulation of levofloxacin.
Slovenian: Ta indikacija je odobrena za tablete in i.v.
English: Therefore, it was agreed to reflect in the SmPCs for both tablets and IV that Tavanic is indicated for the treatment of CAP in adults only when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of these infections.
Slovenian: obliko odražati, da je zdravilo Tavanic indicirano za zdravljenje ZBP pri odraslih samo, kadar se uporaba splošno priporočenih protibakterijskih sredstev za začetno zdravljenje teh okužb šteje za neustrezno.
English: • cSSTIs (IV solution): 500 mg twice daily;
Slovenian: raztopina): 500 mg dvakrat dnevno.
English: 56 (4x14) tablets (multipack)
Slovenian: 56 (4x14) tablet (večkratno pakiranje)
English: Film-coated tablet Oral use blister (PVC/PE/PCTFE/Alu)
Slovenian: 12,5 mg/75 mg/50 mg filmsko obložena tableta peroralna uporaba pretisni omot (PVC/PE/PCTFE/Alu)
English: - 5.0 µg in 0.5 ml.
Slovenian: v 0,5 ml.
English: Invented name Strength Pharmaceutical Form Route of Administration Packaging
Slovenian: Številka EU Izmišljeno ime Jakost Farmacevtska oblika Pot uporabe
English: EU/1/99/104/001 Procomvax
Slovenian: EU/1/99/104/001 Procomvax suspenzija za injiciranje intramuskularna uporaba viala (steklena)
English: Polyribosylribitol phosphate (PRP) from Haemophilus influenzae type b as PRP-OMPC -7.5 µg Neisseria meningitidis OMPC (outer membrane protein complex of the B11 strain of Neisseria meningitidis subgroup B) - 125 µg Adsorbed hepatitis B surface antigen produced in recombinant yeast cells(Saccharomyces cerevisiae)
Slovenian: OMPC (outer membrane protein complex - beljakovinski kompleks zunanje membrane) Neisserie meningitidis (seva B11 Neisserie meningitidis podskupine B)
English: These measures will help protect the environment.
Slovenian: S temi ukrepi pomagate varovati okolje.
English: 7 days (1 week)
Slovenian: 7 dni (1 teden)
English: • Both you and your partner must use effective contraception.
Slovenian: • Oba s partnerjem morata uporabljati učinkovito kontracepcijo.
English: This schedule is repeated in cycles of 4 weeks.
Slovenian: Ta razpored ponavljate v 4-tedenskih ciklih.
English: There was no effect of food on the overall exposure (AUC).
Slovenian: Hrana ni imela učinka na celotno izpostavljenost (AUC).
English: Each pack contains 1 bottle.
Slovenian: Vsako pakiranje vsebuje 1 plastenko.
English: P-value (Log rank test)
Slovenian: P-vrednost (Log rank test)
English: • Taste changes or loss of taste.
Slovenian: • Sprememba okusa ali izguba okusa.
English: It was reported as serious in one patient.
Slovenian: Poročali so o resnem primeru pri enem bolniku.
English: This includes herbal medicines and other medicines you have bought without a prescription.
Slovenian: To vključuje zdravila rastlinskega izvora in druga zdravila, ki ste jih kupili brez recepta.
English: Tell your doctor immediately if you think you have high blood pressure.
Slovenian: Zdravniku takoj povejte, če menite, da imate visok krvni tlak.
English: This treatment schedule should be continued until disease progression or unacceptable toxicity.
Slovenian: Ta razpored zdravljenja je treba nadaljevati, dokler bolezen ne napreduje ali do nesprejemljive toksičnosti.
English: • Increased amount of protein in the urine.
Slovenian: • Povečana količina beljakovin v urinu.
English: • Increase in number of red blood cells.
Slovenian: • Povečano število rdečih krvnih celic.
English: Decreased appetite
Slovenian: Zmanjšan apetit
English: The following terms have been combined:
Slovenian: Naslednji izrazi so bili združeni v skupine:
English: It is unknown whether tivozanib is excreted in human milk, but the potential exists.
Slovenian: Ni znano, ali se tivozanib izloča v človeško mleko, vendar obstaja verjetnost.
English: • Tiredness and lack of energy.
Slovenian: • Utrujenost in pomanjkanje energije.
English: In the ITT population there was a small numerical difference between the two arms in terms of overall survival.
Slovenian: V populaciji ITT je bila manjša razlika v številkah med dvema krakoma z vidika celokupnega preživetja.
English: Other medicines and Fotivda
Slovenian: Druga zdravila in Fotivda
English: What Fotivda is and what it is used for
Slovenian: Kaj je zdravilo Fotivda in za kaj ga uporabljamo
English: • Blocked ears.
Slovenian: • Zamašena ušesa.
English: Taking with food and drink
Slovenian: Zdravilo skupaj s hrano in pijačo
English: Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Slovenian: Pred začetkom jemanja tega zdravila natančno preberite navodilo, ker vsebuje za vas pomembne podatke!
English: This medicine has not been studied in children and adolescents.
Slovenian: To zdravilo ni bilo raziskano pri otrocih in mladostnikih.
English: Avoid driving or using machines if you feel weak, tired, or dizzy.
Slovenian: Ne vozite ali upravljate strojev, če se počutite šibko, utrujeno ali omotično.
English: Study AV-951-09-301
Slovenian: Študija AV-951-09-301
English: In approximately one-third of the patients, hypertension developed within the first 2 months of treatment.
Slovenian: Pri približno tretjini bolnikov je hipertenzija nastopila v prvih 2 mesecih zdravljenja.
English: High blood pressure is the most serious and a very common side effect (see also in section 2 “Warnings and Precautions”).
Slovenian: Visok krvni tlak je najresnejši in zelo pogost neželeni učinek (glejte tudi poglavje 2 „Opozorila in previdnostni ukrepi“).
English: Do not chew, dissolve or open the capsule before swallowing.
Slovenian: Ne žvečite, raztapljajte ali odpirajte kapsule, preden jo pogoltnete.
English: Tell your doctor if you are taking any of the following medicines; they may decide to change your medication:
Slovenian: Povejte zdravniku, če jemljete katero koli od naslednjih zdravil; morda se bo zdravnik odločil zamenjati zdravilo:
English: Do not take Fotivda:
Slovenian: Zdravila Fotivda ne vzemite:
English: The capsules must be swallowed whole with a glass of water and must not be opened.
Slovenian: Kapsule je treba pogoltniti z vodo in se jih ne sme odpirati.
English: It allows continued monitoring of the benefit/risk balance of the medicinal product.
Slovenian: Omogoča stalno nadzorovanje razmerja med koristijo in tveganjem zdravila.
English: • nafcillin, rifampicin, rifabutin, rifapentin (antibiotics);
Slovenian: • nafcillin, rifampicin, rifabutin, rifapentin (antibiotiki);
English: CYP and UGT in vitro studies
Slovenian: CYP in UGT v študijah in vitro
English: Hypothyroidism should be treated according to standard medical practice.
Slovenian: Hipotiroidizem je treba zdraviti po standardni medicinski praksi.
English: Do not give Fotivda to children and adolescents under 18 years of age.
Slovenian: Ne dajte zdravila Fotivda otrokom in mladostnikom, mlajšim od 18 let.
English: Swallow the capsule whole.
Slovenian: Pogoltnite celo kapsulo.
English: The most important serious adverse reaction is hypertension.
Slovenian: Najpomembnejši resen neželeni učinek je hipertenzija.
English: Average Cmax and AUC0-24hr were not significantly affected (8% increase and 6% decrease respectively).
Slovenian: Na povprečno Cmax in AUC0-24hr ni bilo pomembnega vpliva (8 % povečanje oziroma 6 % zmanjšanje).
English: • Abnormal electrocardiogram (ECG), rapid and/or irregular heart beat.
Slovenian: • Nenormalen elektrokardiogram (EKG), hiter in/ali nepravilen srčni utrip.
English: • Sight problems including blurred vision.
Slovenian: • Težave z vidom, vključno z zamegljenim vidom.
English: • Memory loss.
Slovenian: • Izguba spomina.
English: If you or your partner are taking hormonal contraceptives (the pill, an implant or patch) you must use an additional barrier method throughout treatment and for another month after completing treatment.
Slovenian: Če vi ali vaš partner jemljeta hormonsko kontracepcijo (tableta, vsadek ali obliž) morate uporabiti dodatno pregradno metodo ves čas zdravljenja in še en mesec po zaključenem zdravljenju.
English: • Difficulty speaking
Slovenian: • Težave pri govoru.
English: What you need to know before you take Fotivda
Slovenian: Kaj morate vedeti, preden vzamete zdravilo Fotivda
English: These are all symptoms of high blood pressure.
Slovenian: To so vse simptomi visokega krvnega tlaka.
English: Contraindication of concomitant use
Slovenian: Kontraindikacija za sočasno uporabo
English: See also Section 4 “Possible side effects”.
Slovenian: Glejte poglavje 4 „Možni neželeni učinki“.
English: One patient experienced Grade 4 PRES and hypertension in Study AV-951-09-901.
Slovenian: PRES 4. stopnje in hipertenzijo v študiji AV-951-09-901.
English: • Temporary reduced blood flow to the brain.
Slovenian: • Začasno zmanjšan dotok krvi v možgane.
English: • rosuvastatin (a medicine used to help lower cholesterol levels in your blood);
Slovenian: • rosuvastatin (zdravilo, ki pomaga znižati ravni holesterola v krvi);
English: The safety and efficacy of tivozanib in children and adolescents aged below 18 years have not been established.
Slovenian: Varnost in učinkovitost tivozaniba pri otrocih in mladostnikih, mlajših od 18 let, še nista dokazani.
English: Fotivda must be taken with a glass of water and can be taken either with or without food.
Slovenian: Zdravilo Fotivda je treba vzeti z vodo, jemlje se ga lahko s hrano ali brez nje.
English: • if you have high blood pressure.
Slovenian: • če imate visok krvni tlak.
English: The majority of AST and ALT elevations were not accompanied with concomitant elevations of bilirubin.
Slovenian: Večino povišanj AST in ALT ni spremljalo hkratno povišanje bilirubina.
English: In studies that evaluated the terminal elimination phase, tivozanib had a mean t½ of 4.5 - 5.1 days.
Slovenian: V študijah, v katerih so proučevali fazo končnega izločanja, je imel tivozanib mediani t½ 4,5-5,1 dan.
English: • If you are allergic to tivozanib or any of the other ingredients of this medicine (listed in section 6);
Slovenian: • Če ste alergični na tivozanib ali katero koli drugo sestavina tega zdravila (navedeno v poglavju
English: The next dose should be taken at the next scheduled time.
Slovenian: Naslednji odmerek mora vzeti v naslednjem predvidenem času po razporedu.
English: Gastrointestinal perforation/fistula
Slovenian: Gastrointestinalna perforacija/fistula
English: common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000 to < 1/100), rare (≥ 1/10,000 to < 1/1,000) and not known (cannot be estimated from available data).
Slovenian: Pogostost je določena, kot sledi: zelo pogosti (≥1/10); pogosti (≥1/100 do < 1/10); občasni (≥1/1.000 do < 1/100), redki (≥1/10.000 do < 1/1000) in neznana pogostnost (ni možno oceniti glede na razpoložljive podatke).
English: In vitro protein binding studies have shown that tivozanib is > 99% bound to plasma proteins.
Slovenian: Rezultati študije in vitro vezave na proteine so pokazali, da je tivozanib > 99 % vezan na plazemske beljakovine.
English: Clearance is similar between acute and chronic dosing indicating no time dependent changes in PK.
Slovenian: Očistek je med akutnem in kroničnem odmerjanju podoben, kar kaže, da ni časovno odvisnih sprememb v FK.
English: Tell your doctor who will discuss with you the risks of taking Fotivda to you and your child.
Slovenian: Povejte zdravniku, ki vas bo poučil o tveganju jemanja zdravila Fotivda za vašega otroka.
English: QT/QTc interval prolongation may lead to an increased risk for ventricular arrhythmias.
Slovenian: Podaljšanje intervala QT/QTc lahko vodi do povečanega tveganja za prekatno aritmijo.
English: Risk factors for proteinuria include high blood pressure.
Slovenian: Dejavniki tveganja za proteinurijo vključujejo visok krvni tlak.
English: These may be symptoms of a condition called hand foot skin reaction.
Slovenian: To so lahko simptomi stanja t. i. kožne reakcije roka-noga.
English: Risk factors for hypothyroidism include prior history of hypothyroidism and use of anti-thyroid medications.
Slovenian: Dejavniki tveganja za hipotiroidizem vključujejo anamnezo hipotiroidizma in uporabo antitiroidnih zdravil.
English: No more than one dose of Fotivda must be taken per day.
Slovenian: Na dan se sme vzeti samo en odmerek zdravila Fotivda.
English: Healthcare professions should be aware that elderly patients may be at increased risk of adverse reactions.
Slovenian: Zdravstveni delavci morajo vedeti, da pri starejših bolnikih obstaja večje tveganje za neželene učinke.
English: It works by blocking the action of a protein called vascular endothelial growth factor (VEGF).
Slovenian: Deluje tako, da zavira delovanje beljakovine, imenovane vaskularni endotelijski rastni faktor (VEGF).
English: In a controlled clinical study (AV-951-09-301), in which 25% of patients receiving tivozanib were ≥ 65 years of age, no overall differences was observed in efficacy between elderly and younger patients (see section 4.2).
Slovenian: V kontrolirani klinični študiji (AV-951-09-301), v kateri je bilo 25 % bolnikov, ki so prejemali tivozanib, starih ≥65 let, niso zabeležili razlik v učinkovitosti med starejšimi in mlajšimi bolniki (glejte poglavje 4.2).
English: Before initiating Fotivda, this risk should be carefully considered in patients with risk factors such as hypertension or history of aneurysm.
Slovenian: Pred uvedbo zdravila Fotivda je treba to tveganje skrbno preučiti pri bolnikih z dejavniki tveganja, kot sta hipertenzija ali anamneza anevrizme.
English: • Inflammation of the pancreas causing severe stomach pain which may spread to your back.
Slovenian: • Vnetje trebušne slinavke, ki povzroči hudo bolečino v trebuhu, ki se lahko razširi na hrbtni del.
English: • Watery eyes.
Slovenian: • Vodene oči.
English: As CYP1A1 is primarily expressed in extrahepatic tissues such as the lung and intestine, it was considered unlikely that this isoform would be extensively involved in hepatic metabolism.
Slovenian: Ker je CYP1A1 primarno izražen v ekstrahepatičnih tkivih, kot so pljuča in črevesje, se smatra, da ni verjetno, da bi bila ta izooblika obsežno vključena v jetrno presnovo.
English: Carcinogenesis Carcinogenicity studies have not been performed with tivozanib.
Slovenian: Študij kancerogenosti s tovzanibom niso opravili.
English: See the end of section 4 for how to report side effects.
Slovenian: Glejte na koncu poglavja 4, kako poročati o neželenih učinkih
English: There are no data from the use of tivozanib in pregnant women.
Slovenian: Ni podatkov o uporabi tivozaniba pri nosečnicah.
English: Urticaria Dermatitis26
Slovenian: Urtikarija Dermatitis26
English: The efficacy of tivozanib in the treatment of advanced RCC was studied in the following randomised clinical study.
Slovenian: Učinkovitost tivozaniba pri zdravljenju napredovalega RCC so proučevali v naslednji randomizirani klinični študiji.
English: Albumin is the major tivozanib binding component in human plasma.
Slovenian: Albumin je najpomembnejša komponenta, na katero se veže tivozanib v človeški plazmi.
English: Moderate CYP3A4 inducers are not expected to have a clinically relevant effect on tivozanib exposure.
Slovenian: Zmerni induktorji CYP3A4 pričakovano nimajo klinično pomembnega učinka na izpostavljenost tivozanibu.
English: Reporting suspected adverse reactions after authorisation of the medicinal product is important.
Slovenian: Poročanje o neželenih učinkih Poročanje o domnevnih neželenih učinkih po izdanem dovoljenju za zdravilo je pomembno.
English: Do not throw away any medicines via wastewater or household waste.
Slovenian: Zdravila ni dovoljeno zavreči v odpadno vodo ali med hišne odpadke.
English: Printing ink (blue)
Slovenian: Tiskarska barva (modra)
English: • Do not breast-feed during treatment with Fotivda, as it is not known whether the active ingredient in Fotivda passes into breast-milk.
Slovenian: • Ne dojite, ko jemljete zdravilo Fotivda, saj ni znano, ali učinkovina v zdravilu Fotivda lahko preide v materino mleko.
English: Clinical studies with tivozanib were conducted in RCC patients with serum creatinine concentration ≤ 2 times the upper limit of normal, including those who may have had a prior nephrectomy.
Slovenian: Klinične študije s tivozanibom so bile opravljene pri bolnikih z RCC, ki so imeli koncentracijo kreatinina v serumu ≤ 2-krat nad zgornjo mejo normalne vrednosti, vključno s tistimi, ki so morda že imeli predhodno nefrektomijo.
English: One patient died as a result of uncontrolled hypertension in the setting of a suspected overdose.
Slovenian: En bolnik je umrl zaradi neobvladljive hipertenzije v okoliščinah domnevnega prevelikega odmerka.